Hepatitis a Virus Infection in Guillain-Barré Syndrome by Ratnasari, N. (Neneng) & Nurdjanah, S. (Siti)
The Indonesian Journal of Gastroenterology Hepatology and Digestive Endoscopy58
CASE REPORT
Hepatitis A Virus Infection in Guillain-Barré Syndrome
Neneng Ratnasari, Siti Nurdjanah
Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine,
University of Gadjah Mada/Dr. Sarjito Public General Hospital,Yogyakarta
ABSTRACT
Background
Prodromal factors of Guillain-Barré syndrome (GBS) are often associated with previous viral infection
(60%). The ailment supported by the acquired immunomediated disorder concept. Viral hepatitis is very
rarely found in GBS, preceded by cytomegalovirus (15-18%), Campylobacter jejuni (28%), and Epstein-Barr
virus (5%). There is no specific etiology of GBS because those viruses usually appear sporadically
(subclinically). All hepatitis virus infection can cause neurological complications, including GBS.
Case Report
We report two cases of hepatitis A virus infection (HAV) in GBS patients in Dr. Sardjito General Hospital
during 5 years of observation (1996-2000) from 92 GBS patients. The diagnosis of HAV was based on more
than 2 times increment of transaminase enzyme, positive IgM anti HAV, negative HbsAg, and negative IgM
anti HCV. The diagnosis of GBS was based on clinical symptoms of acute generalized paralysis,
cerebrospinal fluid examination, and electromyelography. In both cases, sub-clinical and sporadic
symptoms appeared several days before paralysis, which makes it more likely that the prodromal period of
GBS occurred at the same time of HAV incubation period.
Discussion
The incidence of HAV in GBS patients during 5 years of observation was 2%. This corresponds with the
case reported by Verona et al, 1996 and Pelletier et al, 1985, i.e. the presence of peripheral neuropathy
(n. facialis and n. occulomotorius). Possible alternative pathways for hepatitis virus complicating as GBS
are perivascular and endometrial peripheral nerve infiltration by mononuclear cells, T cell sensitization,
stimulation of IL-2 growth factor surface receptor, and B cell stimulation. All of the conditions mentioned
above causes necrotizing arteritis, vascular occlusion, and at the end, segmental demyelinization.  Hepatitis
virus may replicate in the central nervous system or peripheral nervous system, subsequently developing into
multiple neuropathy disorder and polyarteritis.
Conclusion
The diagnoses of HAV and GBS in both cases were established. HAV is one of several viruses that may
trigger GBS. In both cases, HAV infection was sub-clinical and sporadic. Symptoms of hepatitis infection
subsided along with improvements in the patient’s neurological status.
Acute viral hepatitis has a wide clinical spectrum and laboratory manifestation that is in accordance with
the severity, varying from unclear symptom (anicteric) to jaundice. Acute hepatitis A, B, C infections have the
same symptoms in general. However, hepatitis B and C tend to be more severe. The mildest symptoms are
transaminase enzyme level increment, no jaundice, gastrointestinal symptoms, flu-like symptoms, and
sometimes it can not be diagnosed. The more severe symptoms are jaundice with obvious generalized
symptoms.1 The incidence of hepatitis A is difficult to be determined accurately because of its characters, i.e.
sporadic, endemic, and has a high rate of asymptomatic infection.2,3,4
Guillain-Barré syndrome (GBS) is a disorder of the peripheral nervous system, occurring as a clinical
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syndrome with unknown etiology. The syndrome is characterized by acute onset, generalized, involving the
radix and peripheral nerve, and sometimes central nervous system. GBS is one of the nerve disorders with
peripheral nerve demyelinization (demyelinating motor neuropathy) and usually occur very discreet. The
disease can be  accompanied by HIV, Campylobacter jejuni, hepatitis, mononucleosis, and Mycoplasma
pneumoniae infections, vaccination,  surgery, lymphoma, or systemic lupus erythematosus.5 Acute hepatitis
infection is rare in GBS patient, MacLeod (1987) reported 3 GBS patients as complication of acute hepatitis,
and quoting a report by Berger et al (1981) between year 1944-1980, 26 GBS patients were related with viral
hepatitis,6 with incidence of 1-2 per 100,000 per year, ranging from young adult to 55 years old, occurring
more in males than females (2:1).5,7
The objective of this case report is to present 2 cases of hepatitis A virus in GBS patients who were
hospitalized in RSUP Dr. Sardjito, during 5 years observation (1996-2000). The problem found was that
such cases were rare.
CASE REPORT
Case 1
A 19 year-old, male student , was hospitalized for 34
days in the neurology ward. The patient was admitted to
the hospital due to high fever for 2 days, headache,
nausea, and epigastric pain since 3 weeks prior to
admission. The patient went to a physician and the fever
subsided, while the nausea and headache remained. His
stomach was distended, his urine was tea-like in color,
and he had an irregular frequency of defecation. Five
days prior to admission both of the patient’s legs
became weak and heavy, while the color of his urine still
resembled the color of tea, but there was no longer any
fever. Three days prior to admission, the patient’s
complaints worsened. He became unable to walk, and
could not feel either arms, particularly the fingertips.
Since one day prior to admission, he was unable to
urinate. There was no past history of disease, and he
had had no surgery or vaccination recently. There was
no familial history of disease.
During physical examination the patient was found
to be generally weak, fully conscious, with a blood
pressure of 170/100 mmHg, a pulse rate of 80x/minute,
a respiration rate of 20x/minute, and a body temperature
of 37ºC. His conjunctivae were not pale, and his sclerae
were not jaundiced. There was no neck stiffness. There
were no palpable lymph nodes. Heart and lungs were
within normal range. His liver and spleen were not
palpable. Peristalsis was within normal range. There was
flaccid tetra-paresis, and no edema.
Neurological state: there was no abnormality of the
cranial nerves, abdominal wall reflex was decreased.
Extremities: movement was limited, motor strength
scale 4, physiologic reflexes were decreased. There were
no pathologic reflexes. Muscle tone was normal,
eutrophy, no clonus. Sensibility: acral paresthesia.
Vegetative function: urine retention.
The results of laboratory examination were as
follows: Hemoglobin level 12.1 g/dL; leukocyte count
8,500/mm3; segmental leukocyte composition 71%,
lymphocyte 29%; platelet count 337,000/mm3;
hematocryte 36.0; SGOT 140 iu/L; SGPT 197 iu/L; total
bilirubin 2.10 mg/dL; direct bilirubin 1.13 mg/dL; total
protein 7.4 g/dL; albumin 4.4 g/dL; cholesterol 256
g/dL; triglyceride 348 mg/dL; HDL 26 mg/dL; LDL 160
mg/dL; Ca 2.14; cito blood glucose 141 mg/dL, ureum
level 37 mg/dL; creatinine level 1.0 mg/dL; Na+ 133
mmol/L; K+ 4.3 mmol/L; Cl-  95 mmol/L. Results of blood
gas analysis were as follows: pH 7.45; pCO2 36; pO2
85; HCO3 23.8; TCO2 24.8; BE 0.7; Sat 96%.
Seromarkers for viral disease were as follows:
negative HBsAg, positive anti HAV IgM (1.20), negative
anti HCV IgM. Evaluation of anti CMV IgM/IgG was not
performed due to financial reasons, and other means for
viral disease examinations were not available.
Cerebrospinal fluid analysis (on the 16th day of
hospitalization) demonstrated: no cells; erythrocyte +;
glucose 62 mg%; Na+ 141; K+ 2.6; Cl- 118; protein 53%;
NaCl 694 mg%; no CRP; no albumin; negative pandy
test. The neuropathological evaluation of cerebrospinal
fluid found 1-5 cells, consisting of lymphocytes and
monocytes. These findings suggested post-myelitis,
recovery stage.
The results of electroneuromyelography were as
follows: prolonged distal motor latency of the right and
left tibial nerves; delayed nerve conduction velocity of
right and left tibial nerves; grave neuropathy of right and
left peronei nerves; positive M and H waves; no reflexes.
During hospitalization, the patient suffered from skin
infection i.e. crystalized miliaria (on the 4th day of
hospitalization) and urinary tract infection with 107
citrobacter  (on the 15th day of hospitalization).
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Case 2
A 43 year-old, male civil servant , was hospitalized at
Dr. Sardjito hospital for 12 days. The patient came to
the hospital with complaints of weakness in the lower
extremities for about 10 days prior to admission,
preceded by fever 1 week before.
Weakness of the extremities aggravated to the point
where he found it hard to walk. There were also
nausea, vomiting, bloating, stomachache, and the color
of the patient’s urine resembled the color of tea. The
patient was hospitalized at Klaten hospital for 1 week
and then referred to Dr. Sardjito hospital. Neither the
patient nor any family member had ever suffered from
the same disease before.
The results of the physical examination were as
follows: the patient’s general condition was weak. He
was fully conscious and had a good nutritional status.
Vital signs were as follows: blood pressure 120/80 mmHg,
pulse rate 88x/minute, respiration rate 20x/minute, and
body temperature 37ºC. His conjunctivae were not pale,
his sclerae were not jaundiced, and his pupils were
isochor. There was no neck stiffness. His lymph nodes
were not palpable. Heart and lung findings were within
normal range. His liver and spleen were not palpable.
Peristalsis was within normal range. There was flaccid
tetraparesis, and no edema.
Neurological evaluation findings were as follows:
there was no cranial nerve abnormality; there was L1
(right) and L2 (left) dermatomal hypestesia; the motor
strength of the upper extremities were 4, the lower
extremities 0; physiologic reflexes of both extremities
were decreased; muscle tone was normal, eutrophy;
there were no pathologic reflexes; negative clonus;
vegetative function was within normal range.
Laboratory examination results were as follows:
Hemoglobin 14.9 g/dL; leukocyte count 19,200/mm3,
segment composition 76.6%, lymphocyte 16.1%,
monocyte 4.7%, eosinophil 2.5%, basophil 0.1%;
platelet count 238,000/mm3; hematocryte 45.5%; SGOT
163 iu/L; SGPT 342 iu/L; blood glucose 70 mg/dL, ureum
level 70 mg/dL; creatinine level 1.72mg/dL; Na+ 135
mmol/L; K+ 4.8 mmol/L; Cl- 95 mmol/L. A week later,
laboratory examinations were repeated, resulting in the
following findings: SGOT 154 iu/L; SGPT 195 iu/L; total
bilirubin 0.4 mg/dL; direct bilirubin 0.2 mg/dL, alkaline
phosphatase 323 iu/L, gamma GT 81 iu/L, total protein
7.4 mg/dL, albumin 4.5 mg/dL.
Seromarkers for viral infection were as follows:
negative HBsAg, positive anti HAV IgM (1.40),
negative anti HCV IgM. Results of TORCH
examination: anti toxoplasma IgM 0.229 (cov 0.513),
antitoxoplasma IgG 11.4 (<45: (-)), anti Rubella IgM 0.241
(cov 0.290), anti Rubella IgG 31.7 (moderate immunity
protection), anti CMV IgM 0.290 (cov  0.291),  anti CMV
IgG 31.7 (>115 : latent infection), anti HSV1 1/80 (+),
and anti HSV1 IgM 1/20 (-).
Findings of cerebropinal fluid analysis (on the 1st day
of hospitalization) were as follows: there were no cells;
no erythrocytes, negative rivalta; glucose 70 mg%;
protein 19%; NaCl 694 mg%; no albumin; no globulin;
no CRP; negative pandy. Conclusion: suspected Guillain-
Barré syndrome.
Results of electroneuromyelography (ENMG) were
as follows: prolonged distal motor latency of right and
left tibial nerves; delayed nerve conduction velocity of
right and left tibial nerves; grave neuropathy of right and
left peronei nerves; positive M and H waves; and no
reflexes. During hospitalization there were no other
infection, the patient’s general condition improved, and
subsequent liver function testing demonstrated progress.
The patient left the hospital by his own choice on the
12th day.
In both cases the premiere diagnoses were (1)
observation of flaccid tetraparesis with the following
differential diagnosis: Guillain-Barré syndrome, myelitis,
spinal medulla tumor; (2) acute hepatitis.
The therapy given were: intravenous fluid drop using
Ringer Lactate, liver diet III, oxygen 2l/minute (when
needed), injection of roborantia, hepatoprotective agents,
antibiotics in the presence of infection was proven
(in case 1), urine catheterization in case 1, and
physiotherapy.
Based on the physical examination, laboratory
findings and auxiliary examination, the final diagnosis of
both cases was Guillain-Barré syndrome with acute
hepatitis A virus infection (sporadic).
DISCUSSION
Prodromal factors leading to GBS are associated with
preceding viral diseases (virus-like illness). GBS is
supported by acquired immunomediated disorder
concept. The viral diseases stated before include upper
respiratory tract infection (CMV titer 15-18%),
gastrointestinal tract infection (Campylobacter jejuni
titer of 28%), Epstein-Barr virus infection (5%), HIV,
Hepatitis, Mycoplasma (5%), post vaccination (tetanus
toxoid, influenza, rabies, polio), and post surgery
(10%).5,7,8,9 Viral infections as the main prodromal of
GBS (40-60%),   usually occur in the first to fourth week
since the appearance of viral infection symptoms until
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the neuropathy symptoms. There is no specific etiology
that can be implemented to most of the GBS patient
because the virus usually appears sporadically based on
the clinical diagnosis, antibody response, or virus
isolation.6,8,10 All types of viral hepatitis might lead to
neurological complications including GBS.4
The pathogenesis and the pathophysiology of the GBS
are based on findings of perivascular and endometrial
peripheral nerve infiltration by the mononuclear cells, an
immune component related with segmental
demyelinization, which clinically mimics allergic neuritis
in laboratory animals. In the acute phase of GBS, there
is T cell sensitization towards P0 protein, P2 protein and
peripheral nerve myelin, which shows the existence of
cellular immunity disorder. The T cell will anonymously
present growth factor IL-2 surface receptors when
stimulated by antigen or mitogen. Serum IL-2 (soluble
IL-2 receptors) concentration increment indicates T cell
activity. T cell activation can be triggered by B cells
through several ways: production of anti-myelin antibody,
activation of the complement system or action as
effectors using the cytotoxic activity against myelin or
schwann cells.5,10,11,12
Based on the findings and the validity of the
immune-mediated demyelinization existence, researcher
suggests the use of plasmapheresis to reduce clinical
symptoms.10,13
Only a small number of literature states the relation
between hepatitis and GBS, though the viral hepatitis
infections are common. As reported by Berger et al
(1981) who collected data since 1944-1980, only 26 of
viral hepatitis cases were correlated with GBS. Macleod
(1987) reported 3 cases of non-A and non-B viral
hepatitis-correlated GBS out of 26 GBS cases.6  Kippel,
(1993) reported 1 case of viral hepatitis type C in a GBS
patient.14 Liver function disorder in GBS might occur in
conjunction with viral hepatitis and other virus infection
during the prodromal phase of GBS, or during the acute
phase with negative serologic test (CMV, EBV, HAV,
HBV). The last could be explained by the
synchronization between immune mediated regulation
disorder of the liver and peripheral nervous system,
proven by the administration of intravenous
immunoglobulin preventing the development of
hepatitis.
In approximately 10 recent years, sub-clinical
hepatitis B virus infections are reported as the
prodromal factor of GBS, which occur during the
incubation period and pre-jaundice phase of hepatitis B
virus infection. The cerebrospinal fluid is normal or in
other words there is no protein increment and
pleocytosis. HBV infection is related with acute arteritis
(30% of positive HbsAg in patient with periarteritis).
Research on immunofluorescence demonstrated the
existence of antigen, immunoglobulin, and complement
on the inflamed blood vessel wall. This suggests that
antigen-antibody complexes are accumulated in the blood
vessel or formed on the blood vessel wall, and conversely
the activation of complement might be represented by
acute tissue damage. The antigen-antibody complexes
might reach the small vessels of the central nervous
system and peripheral nervous system, which causes
necrotizing arteritis and vascular occlusion, resulting in
central nervous system focal disorder, and multiple
mononeuritis. Based on the above, HBV virus infection
in GBS have no relation with arteritis, but it is more likely
that HBV replicates in the central nervous system,
proven by the existence of HBV in the cerebrospinal
fluid and the absence of in the serum.6,8,12,14
Verona et al, 1996,16 reported a case of acute HAV
infection involving peripheral neuropathy (n. facialis and
n.occulomotorius), that improved without residual
symptoms in four weeks time. Verona et al quoted
a research by Pelletier et al (1985) that only four out of
10,000 viral hepatitis patient experienced facial nerve
neuropathy, two of them being viral hepatitis type A
patients. Symptoms of neuropathy were subtotal and
improved completely, appearing before and after the liver
function disorders. Temb et al, 1999,17 reported nine  viral
hepatitis type C patients with neurological complications,
seven of them suffering from chronic sensory
polineuropathy, multi-neuropathy and encephalopathy
associated with cryoglobulinemia.
Based on the observation of the hospitalized GBS
patients in Dr. Sardjito General Hospital in five years
time (January 1996-Desember 2000), there were only
92 GBS patients recorded. More than twofolds
increment from the normal transaminase enzyme level
was found in only 21 cases (22.82%). Three patients
suffered from hepatitis (3.26%) and two of them was
proven to be infected by HAV (HbsAg (+); TORCH
(-) while no serological tests for either HAV or HCV
were performed on the second patient. Infection of other
viruses besides hepatitis virus were CMV in four
patients (4.35%), two of them were in the acute phase
of infection (IgM (+), while the others were in the latent
period of infection. In addition, there were two patients
(2.17%) with IgG HSV1 (+) and one patient with IgG
HSV2 (+). Mortality was found in three cases with
respiratory failure as the cause of death.
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SUMMARY
Two hospitalized patients at Dr. Sardjito General
Hospital were reported to suffer from viral hepatitis type
A accompanying Guillain-Barré syndrome in five years
observation (1996-2000). Hepatitis virus infection is the
prodromal factor in GBS, which occurs during the first
to fourth week since the first appearance of viral
infection symptoms until neuropathy appears. There is
no specific etiology to prove the cause of GBS due to
sporadic virus appearance, based on the clinical
diagnosis, antibody responses or viral isolation.
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